EMILIA GUCCIARDO: Open Payments
NPI 1437714086 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 59 payments from 11 companies in 2025. Trend: 2023 $303 · 2024 $529 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $478 |
| Amgen Inc. | 9 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $104 |
| Ionis Pharmaceuticals, Inc. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| ABIOMED | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| Cleerly, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $23 |
Products named: Wegovy, REPATHA, Kerendia, LEQVIO, EVKEEZA, Ozempic, TRYNGOLZA, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
